ScreenerHero

OXUR Oxurion NV

EBR · BE · Healthcare · Biotechnology · oxurion.com
0.0010EUR-37.50%Mkt Cap: 191792 $P/E: —

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap191.79K USD
Enterprise Value12.84M USD
Revenue (TTM)1.25M USD
Gross Profit603.26K USD
Net Income (TTM)-4.05M USD
Revenue/Share0.02 EUR
Last Price0.0010 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees26
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0003846632
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-5.33
EV/Revenue10.31
P/S0.25
P/B-0.01
EPS (TTM)-0.13
EPS (Forward)-0.47
52W Range
0.00100% of range0.0188
52W High0.0188 EUR
52W Low0.0010 EUR
Profitability
Gross Margin100.00%
Oper. Margin-127.75%
EBITDA Margin-193.46%
Profit Margin-671.71%
ROE28.92%
ROA-97.46%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.85M USD
CapEx (TTM)—
FCF Margin-95.33%
FCF Yield-619.16%
Net Debt12.48M USD
Net Debt/EBITDA-5.18
Balance Sheet
Debt/Equity-0.89
Current Ratio0.09
Quick Ratio0.09
Book Value/Sh-0.15 EUR
Cash/Share0.00 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10000
Split DateSep 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.176.45M
Float78.71M
Insiders11.37%
Institutions0.00%
Technical
SMA 500.0024 (-59.0%)
SMA 2000.0042 (-76.5%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)2.26M
Avg Vol (10d)3.03M
Technical Indicators
RSI (14)30.1
MACD-0.0003
MACD Signal-0.0003
MACD Hist.-0.0001
BB Upper0.0032 EUR
BB Middle0.0020 EUR
BB Lower0.0009 EUR
BB Width110.93%
ATR (14)0.0004 EUR
Vol Ratio (20d)11.32x